Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Advertising Division
Marketing
NAD reaches split decision on Kenvue-Hims & Hers hair ad row
The NAD delivered a mixed verdict, telling Hims & Hers Health to change certain claims while dismissing other challenges brought by Kenvue.
Nick Paul Taylor
Aug 25, 2026 3:38am
Quanovate scratches marketing claims for Mira fertility wand
Aug 17, 2026 2:50pm
Sanofi asked to change Dupixent ads after Galderma challenge
Aug 6, 2026 7:40am
Eli Lilly wins argument over Noom’s GLP-1 dosing claims
May 27, 2026 2:09am
Semaglutide compounder drops claims after Novo Nordisk challenge
Nov 21, 2025 9:20am
Pfizer's challenge of BridgeBio ads referred to federal agencies
Nov 10, 2025 11:15am
